Imaging association takes shapeShimadzu joins European trade group
Comm system promotes MR interventions
The loud and distracting noises made during MR scans pose a communications obstacle to interventionalists. A fiber optics-based system that allows interventionalists to converse normally while performing procedures promises to be a solution. The IMROC (Interventional MR Optical Communication) System, developed by Optoacoustics, supports up to eight concurrent dialogs among doctors and technicians, according to the company. It was recently installed at the University of Texas M. D. Anderson Cancer Center.
Imaging association takes shape
Independent diagnostic testing facilities, radiologists and oncologists have a new voice. A national coalition of professionals representing medical imaging vendors and diagnostic clinics have formed the Imaging Radiology Oncology Association. One objective is to increase the public's awareness of the benefits of diagnostic procedures that detect cancer early. Another is to lobby Congress and the public to recognize independent diagnostic testing facilities as a means to reduce the overall cost of healthcare.
Shimadzu joins European trade group
Shimadzu Medical Systems has joined COCIR, a non-profit trade association that represents members of the European radiological, electromedical and healthcare IT Industry. COCIR gathers and analyzes data about medical imaging activities in the European Union and other countries.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Researchers Show Higher Breast Cancer Upstaging Rate with 18F-FAPI PET/CT
September 9th 2024The imaging agent 18F-FAPI PET/CT demonstrated greater than a 45 percent higher sensitivity rate in comparison to 18F-FDG PET/CT for the detection of axillary and extraaxillary regional lymph node metastases, according to a lesion-based analysis from a recent study.